Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12059408 Treatment of cognitive impairment associated with schizophrenia

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 11, 2021
0
Date of Patent
August 13, 2024
0
Patent Application Number
17399094
0
Patent Citations
‌
US Patent 7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent
0
‌
US Patent 7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
0
‌
US Patent 7557114 Heterocyclic-substituted phenyl methanones
0
‌
US Patent 7951836 Substituted phenyl methanone derivatives
0
‌
US Patent 8188139 Heterocyclic-substituted phenyl methanones
0
‌
US Patent 8497289 3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same
0
‌
US Patent 8288435 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
0
‌
US Patent 8816079 Amide derivative and use thereof as medicine
0
‌
US Patent 7220744 Monocyclic substituted phenyl methanones
0
‌
US Patent 7317125 Diacylglycerol acyltransferase inhibitors
0
Patent Inventor Names
Yihua Zhao
0
Sun Young Yum
0
Jana Podhorna
0
Holger Rosenbrock
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12059408
0
Patent Primary Examiner
‌
Kamal A Saeed
0
CPC Code
‌
A61P 25/18
0
‌
A61P 25/28
0
‌
A61K 31/422
0

Find more entities like US Patent 12059408 Treatment of cognitive impairment associated with schizophrenia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo